The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis

Arthritis and Rheumatism

Volumn 40, Issue 12, 1997, Pages 2226-2234

  Hashkes, Philip J ^a   Balistreri, William F ^a   Bove, Kevin E ^a   Ballard, Edgar T ^a   Passo, Murray H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; FOLIC ACID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; JUVENILE RHEUMATOID ARTHRITIS; LIVER FIBROSIS; LIVER TOXICITY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ALCOHOL DRINKING; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; ASPARTATE AMINOTRANSFERASES; BIOPSY; CHILD; FEMALE; FIBROSIS; HUMANS; LIVER; LIVER DISEASES; MALE; METHOTREXATE; SERUM ALBUMIN;

EID: 0031471978     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780401218     Document Type: Article

References (46)

1. Giannini EH, Brewer EJ, Kuzima N, Shaikov A, Maximov A, Vorontsuv I, Fink CW, Newman AJ, Cassidy JT, Zemel LS, for the Pediatric Rheumatology Collaborative Study Group and the Cooperative Children's Study Group: Methotrexate in resistant juvenile rheumatoid arthritis: results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. N End J Med 326:1043-1049, 1992
2. Towner SR, Michet CJ Jr, O'Fallon WM, Nelson AM: The epidemiology of juvenile arthritis in Rochester, Minnesota 1960-1979. Arthritis Rheum 26:1208-1213, 1983
3. Cassidy JT, Petty RE: Textbook of Pediatric Rheumatology. Third edition. Philadelphia, W.B. Saunders Company, 1995
4. Mier R, Bowyer S, Lovell D, Passo M, Rcnnenbohm R, Schikler K, Coates S: Variations in medication choices in JRA. J Clin Rheumatol 2:262-267, 1996
5. US Bureau of the Census: Statistical Abstract of the United States: 1995. 115th edition. Washington DC, US Bureau of the Census, 1995
6. Ravelli A, Viola S, Ramenghi B, Aramini L, Ruperto N, Martini A: Frequency of relapse for clinical remission in juvenile rheumatoid arthritis. J Rheumatol 22:1574-1576, 1995
7. Giannini EH, Cassidy JT: Methotrexate in juvenile rheumatoid arthritis: do the benefits outweigh the risks? Drug Saf 9:325-339, 1993
8. Wallace CA, Sherry DD: A practical approach to avoidance of methotrexate toxicity. J Rheumatol 22:1009-1011, 1995
9. Kremer JM, Alarcón GS, Lightibot RW Jr. Willkens RF, Furst DE, Williams HJ, Dent PB, Weinblatt ME: Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. Arthritis Rheum 37:316-328, 1994
10. Whiting-O'Keefe QE, Fye KH, Sack KD: Methotrexate and histologic hepatic abnormalities; a meta-analysis. Am J Med 90:711-716, 1991
11. Weinstein G, Roenigk H, Maibach H, Cosmides J: Psoriasis-liver-methotrexate interactions. Arch Dermatol 108:36-42, 1973
12. Erickson AR, Reddy V, Vogelgesang SA. West SG: Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients. Arthritis Rheum 38:1115-1119, 1995
13. Roenigk HH, Auerbach R, Maibach HI, Weinstein GD: Methotrexate in psoriasis: revised guidelines. J Am Acad Dermatol 19:145-156, 1988
14. Walker AM, Punch D, Dreyer NA, Tolman KG, Kremer JM, Alarcón GS, Lee RG, Weinblatt ME: Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. Arthritis Rheum 36:329-335, 1993
15. Danao T, Steinbrunner J, Mendendorp SV, Mackenzie AH, Segal AM: Methotrexate in juvenile rheumatoid arthritis (abstract). Arthritis Rheum 32 (suppl 4):S28, 1989
16. Keim D, Ragsdale C, Heidelberger K, Sullivan D: Hepatic fibrosis with the use of methotrexate in juvenile rheumatoid arthritis. J Rheumatol 17:846-848, 1990
17. Graham LD, Myones BL, Rivas-Charcon RF, Pachman LM: Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis. J Pediatr 120:468-473, 1992
18. Kugathasan S, Newman AJ, Dahms BB, Boyle JT: Liver biopsy findings in patients with juvenile rheumatoid arthritis receiving long-term, weekly methotrexate therapy. J Pediatr 128:149-151, 1996
19. Wallace CA: New uses of methotrexate. Contemp Pediatr 11:43-53, 1994
20. Lawson EE, Grand RJ, Neff RK, Cohen LF: Clinical estimation of liver span in infants and children. Am J Dis Child 132:474-476, 1978
21. Cassidy JT, Levinson JE, Bass JC, Baum J, Brewer EJ Jr, Fink CW, Hanson V, Jacobs JC, Masi AT, Schaller JG, Fries JF, McShane D, Young D: A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29: 274-281, 1986
22. Weinstein A, Marlowe S, Korn J, Farouhar F: Low-dose methotrexate treatment of rheumatoid arthritis: long-term observations. Am J Med 79:331-337, 1985
23. Ashton RE, Millward-Sadler GH, White JE: Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis. J Invest Dermatol 79:229-232, 1982
24. Kamen BA, Nylen PA, Camitta BM, Bertino JR: Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug. Br J Haematol 49:355-360, 1981
25. 2) as a measure of fatness. Int J Obes 9:147-150, 1985
26. Centers for Disease Control and Prevention: Youth risk behavior surveillance system questionnaire (appendix II). Public Health Rep 108:60-66, 1993
27. Pearson ES, Clopper CJ: The use of confidence intervals or fiducial limits in the case of the binomial. Biometrika 26:404, 1934
28. Brick JE, Moreland LW, Al-Kawas F, Chang WWL, Layne RD, DiBartolomeo AG: Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid arthritis. Semin Arthritis Rheum 19:31-44, 1989
29. Weinblatt ME, Weissman BN, Holdsworth DE, Fraser PA, Maier AL, Falchuk KR, Coblyn JS: Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84-month update. Arthritis Rheum 35:129-137, 1992
30. Phillips CA, Cera PJ, Mangan TF, Newman ED: Clinical liver disease in patients with rheumatoid arthritis taking methotrexate. J Rheumatol 19:229-233, 1992
31. Mackenzie AH: Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis. Cleve Clin 52:129-135, 1985
32. Aponte J, Petrelli M: Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate. Arthritis Rheum 31:1457-1464, 1988
33. De la Hall PM, Jenner MA, Ahern MJ: Hepatotoxicity in a rat model caused by orally administered methotrexate. Hepatology 14:906-910, 1991
34. Ishak KG, Zimmerman HJ: Morphologic spectrum of drug-induced hepatic disease. Gastroenterol Clin North Am 24:759-786, 1995
35. Thurman RG, Bunzendahl H, Lemasters JJ: Role of sinusoidal lining cells in hepatic reperfusion injury following cold storage and transplantation. Semin Liver Dis 13:93-100, 1993
36. Schaller J, Beckwith B, Wedgewood RJ: Hepatic involvement in juvenile rheumatoid arthritis. J Pediatr 77:203-210, 1970
37. Rich RR, Johnson JS: Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis. Arthritis Rheum 16:1-9, 1973
38. Tolman RG, Lee RG, Clegg DO, Willkens RF, Furst DE, Kremer JM: Hepatic fibrosis is the only lesion characteristic of methotrexate treatment in rheumatoid arthritis (abstract). Gastroenterology 90:1776, 1986
39. Neuschwander-Tetri BA, Bacon BR: Nonalcoholic steatohepatitis. Med Clin North Am 80:1147-1166, 1996
40. Kremer JM, Lee RG, Tolman KG: Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy: a prospective study with baseline and sequential biopsy samples. Arthritis Rheum 32:121-127, 1989
41. Kremer JM, Kaye GI, Kaye NW, Ishak KG, Axiotis CA: Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy: followup over long treatment intervals and correlation with clinical and laboratory variables. Arthritis Rheum 38:1194-1203, 1995
42. Carlos CD, Singsen B, Eichenfield AH, Goldsmith DP, Athreya BH: Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr 17:653-659, 1990
43. Martini A, Ravelli A, Viola S, Burgio RG: Methotrexate hepatotoxic effects in children with juvenile rheumatoid arthritis (letter). J Pediatr 119:333-334, 1991
44. Kremer JM, Furst DE, Weinblatt ME, Blotner SD: Significant changes in serum AST across hepatic histologic biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis. J Rheumatol 23:459-461, 1996
45. Cohen MB, A-Kadar HH, Lambers D, Heubi JE: Complications of percutaneous liver biopsy in children. Gastroenterology 102: 629-632, 1992
46. Giannini EH, Cawkwell GD: Drug treatment in children with juvenile rheumatoid arthritis: past, present and future. Pediatr Clin North Am 42:1099-1125, 1995